Gossamer Bio (GOSS) FCF Margin (QoQ) (2024 - 2026)
Gossamer Bio (GOSS) FCF Margin (QoQ) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.96 Bn | 132.11 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn |
| 4 | Moderna | 60.20 Bn | 55.06 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.19 Bn | 37.09 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.43 Bn | 28.12 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.65 Bn | 10.26 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.16 Bn | 26.32 Bn | - |
| 10 | Gossamer Bio | 47.59 Mn | -9.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -19,838.00 |
| Mar 31, 2026 | 12,175.00 |
| Dec 31, 2025 | -7,807.00 |
| Sep 30, 2025 | 13,802.00 |
| Jun 30, 2025 | -812.00 |
| Mar 31, 2025 | -64,462.00 |
| Dec 31, 2024 | 58,056.00 |
| Sep 30, 2024 | -45,930.00 |